• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Friday, March 24, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Time to buy large-cap US bank stocks? Vaccination, loan growth, other factors to aid growth

by The Outlooker Web Desk
December 31, 2020
in Business
0
Time to buy large-cap US bank stocks? Vaccination, loan growth, other factors to aid growth
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

For US large-cap banks, the growth drivers include higher loan growth. (AP Photo/File)

As the path of economic recovery increasingly looks clearer, analysts are finding buying opportunity in banking shares across the globe. Lenders are expected to benefit with the reopening of the economy as vaccination drive picks up pace in various countries. Global activity is expected to have risen back to pre-covid levels in the fourth quarter of this year and economic growth is forecasted to return to normal in the next few quarters. “We see long end rates rising, loan growth holding up, and banks deploying excess capital and excess reserves accreted through the crisis,” said analysts at global brokerage and research firm Morgan Stanley.

Banks set to fire on all cylinders

The brokerage firm recently upgraded US large cap bank stocks and the consumer finance sector to ‘Attractive’ believing banks are set to fire on all cylinders. “Vaccine distribution enabling US normalization by the end of 2021 is bullish for our coverage. It provides a high degree of certainty that this recession will end in 2021, driving up long-end interest rates, accelerating loan growth, driving down unemployment and allowing banks to resume buybacks,” the report said.

Also Read: Google, Facebook or Twitter? JP Morgan lists its top internet trades for 2021

Aiding their preference for banks is the expectation that by 2022 long-end rates would rise from current levels across most markets. Inflation-adjusted loan growth in most markets is also expected to be relatively steady when compared to the previous two years. 

Digital payments pick up

In 2020, social distancing has helped increase the adoption of digital payments. “Historically, card penetration of consumer spend in the US increases ~2 percentage points per year. The pandemic, and the rapid adoption of contactless payments and eCommerce, has caused a step-function increase in the share of spend captured on cards. Going forward, we expect the annual share gain of card to return to its ~2 percentage point cadence off a higher CY20 base,” analysts at Morgan Stanley said.

Also Read: Looking for portfolio diversification? Here are some great investment ideas for US stock market

For US large-cap banks, the growth drivers include higher loan growth, expected to be at 4.8% by 2022. Morgan Stanley also expects banks to optimise their capital structure as the economic recovery picks up, which is further expected to aid more buybacks.

Morgan Stanley’s top banking stock picks

Wells Fargo
The uncertainty around the impact on business exits is accounted for in the stock at 6.6x Morgan Stanley’s 2022e EPS and 0.7x 3Q20 BV. “Asset sensitivity and expense optimization the main drivers of forward EPS outlook,” they added. The target price for the stock is $40.

Citigroup

Citigroup has been termed as a deep value play in an improving economy. “At just 0.6x NTM BVPS, C is cheap even after factoring in higher expenses from the consent orders. Stock does not reflect Citi’s diverse business mix and more resilient wholesale business,” the report said. The target price for the stock is $79.

Regions Financial

“RF winning the battle against the curve, as hedges add ~30bps to NIM and ~2% pts to ROE. RF undervalued for this level of earnings stability in their business model over the next ~4 years,” Morgan Stanley said. Target price for the stock is $22.

Looking to invest in US Stocks? Open a free account with Stockal – India’s first borderless investment platform.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Minimum Temperature In Delhi Dips To 3.3 Degrees Celsius On New Year’s Eve

Minimum Temperature In Delhi Dips To 3.3 Degrees Celsius On New Year's Eve

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
National

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India

March 24, 2023
Vandalism At Indian High Commission In London Raised In UK Parliament
National

Vandalism At Indian High Commission In London Raised In UK Parliament

March 23, 2023
Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points
National

Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

March 23, 2023
Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation
National

Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation

March 23, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
  • Vandalism At Indian High Commission In London Raised In UK Parliament
  • Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.